Trinity Partners, a leading global life sciences consulting firm, announced that Senior Associate Consultant Zahra Al-Khateeb will present a poster from our work with Array BioPharma at the 13th Congress of the EADO in Athens, Greece from May 3-6, 2017. The event will cover all aspects of melanoma and skin cancers, anywhere from epidemiology, diagnosis and prevention to the results of the latest therapeutic trials in advanced tumors. Zahra will present a poster on the current mutation testing approaches in metastatic melanoma and unmet need in the NRAS+ patient population in the U.S. Learn more about the conference: https://www.erasmus.gr/microsites/1063
Read the Q&A to learn more about her keynote:
Edúcate Sí Se Puede: A Q&A with Trinity Partners Consultant Alessa Moscoso
Last month, we shared that Consultant Alessandra Moscoso, of Trinity’s San Francisco office, was invited to speak at Cuesta College’s Edúcate Sí Se Puede Conference in San Luis Obispo County, California. Following Alessa’s presentation, we sat down with her to explore her insights on the event, which inspired hundreds of students to see the value of pursuing higher education.
Give us a brief overview of the Edúcate Sí Se Puede and the event’s purpose.
The conference was geared towards Latino/Latina youth and promoted college attendance and the importance of hard work in achieving your dreams. In addition, it communicated the importance of not allowing financial aid to prevent students from attending college. While the event has taken place at Cuesta College for several years, this year was the largest in history and by far the most successful, with 500 students from high schools all over San Luis Obispo county volunteering to be there.
Do you have any ties to the event and organization?
Cuesta College is a part of me. My mother works at the college as an academic counselor; she and my father took classes there when I was growing up. During high school, I also took several courses there. My mother was part of the planning committee for this conference and one of her co-workers invited me to keynote the event.
What did you and the other speakers discuss with the group?
I presented an overview of my educational and professional journey up until now. I focused on providing the students with three lessons: realizing the value of hard work and how it pays off; remembering to keep your eyes open to unexpected opportunities and always trying new things; and not worrying about planning your entire life, because it will work itself out.
One speaker talked about switching jobs and majors, and how each contributes to your growth. Another highlighted similar themes to mine — working hard and pursuing your passions. While many of our discussions were similar in theme, we all illustrated these themes in different ways. This worked well to demonstrate to the students that not everyone follows the same path to success and that is completely fine.
How did Trinity benefit from your leadership at this event?
Many of the students at the event were not familiar with what, exactly, consulting is. I focused on familiarizing them with the industry and what we do at Trinity, providing exposure to an entirely new career path that many students don’t hear about until college. Looking toward the future, one student could work at Trinity someday due to this conference! Trinity is a huge supporter of education at all levels and we value opportunities like this to educate students on the industry and the options they have as they consider their career paths.
What were your key takeaways from the event?
Before giving my speech, I worried that my words might not inspire the students enough. Following the event, I realized that what they wanted to hear most is my personal narrative. Watching the other speakers, even I wanted to hear about what they had done and felt invested in learning more. Inspiring others is done by sharing your story, so I was lucky to be able to do that.
Participating in this event inspired me to get involved in more events like it. It isn’t the sort of opportunity you’re given all the time. I believe in our future generations and want to make those generations believe in themselves. At Trinity Partners, we are all excited about the future not only of our company but of the healthcare and consulting industries as a whole. Oftentimes, you don’t realize your potential impact until you’re reminded of it through unconventional opportunities like this.
Trinity Partners, a leading global life sciences consulting firm, announced that their client, Akcea Therapeutics, a wholly owned subsidiary of Ionis Pharmaceuticals, Inc., has published results from one of the first-ever research studies measuring the considerable burden of patients with familial chylomicronemia syndrome (FCS) and the impact the disease has on their activities of daily living and employment. The results, from an interim analysis of the largest survey in patients with FCS, were published in Expert Review of Cardiovascular Therapy.
FCS, also known as lipoprotein lipase deficiency (LPLD) or type I hyperlipoproteinemia, is a rare genetic disease characterized by extremely high levels of triglycerides and increased risk of other health complications, including pancreatitis. IN-FOCUS, a comprehensive web-based research survey of patients with FCS, was designed to capture the associated burden of illness and impact on quality of life. Sixty patients from the United States diagnosed with FCS participated; patients described multiple symptoms spanning across physical, emotional and cognitive domains.
An analysis of the survey data found that patients with FCS saw five physicians on average with FCS-related symptoms before receiving a proper diagnosis. Nearly all respondents reported frequent, debilitating symptoms leading to reduced quality of life. Respondents also indicated that FCS significantly influenced their career choice and employment status, and resulted in substantial work loss.
Learn more about the study results: http://bit.ly/2oNlzbE
Read Endocrine Today’s article on the findings: http://bit.ly/2oaDxDE
Conference season is in full swing! Trinity team members have been busy gaining insight by attending and presenting at some of the industry’s most influential events.
Last week, Partner Herman Sanchez attended the World Orphan Drug Congress in Washington, D.C. The event focused on scientific innovation and commercialization, and explored trends in digital health, biosimilars and gene therapy. This week, Director of Analytics & Insight Kevin Francis, Director of Advanced Analytics Todd Foster and Engagement Manager Susheel Sukhtankar are attending the Pharmaceutical Management Science Association (PMSA) Annual Conference in Orlando, Florida to learn about the latest trends and developments in pharmaceutical analytics.
Learn more about the World Orphan Drug Congress here: http://www.terrapinn.com/conference/world-orphan-drug-congress-usa/index.stm
Read up on the 2017 PMSA Annual Conference here: http://www.pmsa.net/conferences/2017-annual-conference
Trinity Partners, a leading global life sciences consulting firm, announced that Steve Yonish, Gordon Lau and Monique Marsh will attend the PMRG 2017 CONNECT conference in Orlando, Florida from April 24 – 26. The event brings together insights professionals focused on navigating a rapidly evolving healthcare landscape and employing an expanding variety of quantitative and qualitative tools. As the premier healthcare marketing research community, PMRG offers the 2017 CONNECT attendees an opportunity to discuss systemic, strategic issues affecting the industry, while also providing thought-provoking examples to help navigate their market support needs back at the office. Learn more about the conference: http://bit.ly/2oEI8fo
On April 5th, Trinity Partner Herman Sanchez will speak on a panel at the second annual Pharmacy Industry Summit, organized by Mintz Levin, discussing the current drug pricing debate and the evolving roles of pharmacy industry players. The conference brings together stakeholders and thought leaders from across the country to discuss legal and policy challenges facing manufacturers, PBMs, payers, pharmacies and providers. View the agenda here: http://bit.ly/2nBffiA
The conference brings together Latino and Latina High School students in San Luis Obispo County, motivating them to aim for success in college, helping them to identify career goals and coaching them on how to achieve their goals. Learn more about the inspiring event: http://bit.ly/2nibqyM
Trinity Partners, a leading global life sciences consulting firm, had several company experts attend the 2017 AMCP Managed Care & Specialty Pharmacy Annual Meeting from March 27-30 in Denver, Colorado.
Trinity employees presented two posters at the annual meeting. The first, titled, “Determining the Cost of Care for Spinal Muscular Atrophy (SMA) using Retrospective Claims Analysis,” was created by several Trinity employees in association with Biogen to help support the highly-anticipated launch of Spinraza. The second poster, titled, “Utilization of Geriatric Care among Medicare Beneficiaries” was developed with the help of Trinity’s statistics team.
The AMCP Managed Care & Specialty Pharmacy Annual Meeting is designed to bring together managed care pharmacists, health plan administrators, medical directors, formulary decision-makers and other industry leaders to discuss breakthrough drug therapies, updates in legislation and regulation, research and formulary management.
Learn more about the conference here: http://bit.ly/1H4ZuUK
He asserts that the first product to offer patients the ability to self-administer at home could drive separation from the pack. Read more: http://bit.ly/2nBn2Bm
Trinity Partners has appointed Kevin Francis to director of analytics & insights, and Alex Chiang will serve as principal. Both employees have experienced continued growth with the firm, with a tenure of almost twelve and ten years respectively.
In his new role, Kevin will be responsible for leading a team of analytics professionals that focus on leveraging secondary data to drive actionable insights for pharmaceutical and biotechnology clients. He will continue leading the firm’s charge on large-scale data integration engagements involving patient claims and transactional sales data. Kevin will also partner with the strategy consulting team to integrate secondary data into their projects.
Kevin graduated from Bentley University with an Economics degree. He has contributed analyses for several publications, including the Journal of Medical Economics and the Journal of Clinical Epidemiology. Kevin’s work has also been presented at conferences and events, including the Academy of Managed Care Pharmacy Annual Meeting, the ASH Annual Meeting and the ISPOR Annual Meeting. He has been with Trinity for more than eleven years and most recently served as engagement manager, advanced analytics.
“Kevin possesses a deep understanding of secondary data, and has leveraged that knowledge to drive actionable insights for clients.” said Dave Fitzhenry, managing partner, Trinity Partners. “Further, as he has transitioned into a leadership role, he has developed innovative processes to help refine Trinity’s data management and analytics capabilities. Not only do clients clamor to work with him, colleagues rely on Kevin and his team for quick turnaround help on important projects.”
Alex, who has been with Trinity since 2007, will continue advising life sciences clients on a range of therapeutic areas, including oncology and specialty diseases. He has had significant exposure across Trinity’s strategic offerings and practice areas, including forecasting, advanced analytics, corporate strategy, and primary market research. Alex will also continue to lead Trinity’s New York City office.
Alex received an Economics degree and a certificate in American Studies from Princeton University and an MBA from Columbia. His analysis on personalized medicine in oncology was published in Nature Reviews Drug Discovery.
“Alex is a natural leader and mentor to many Trinity employees. Accordingly, he quickly rose through the ranks from associate to engagement manager and now principal,” said Fitzhenry. “Alex has also demonstrated a knack for partnering with clients to help them maximize current assets and develop a roadmap to success across therapeutic areas.”
These promotions are an indication of Trinity’s ongoing growth. Based just outside of Boston, the company has additional offices in San Francisco, Princeton and New York City. Throughout Trinity’s twenty plus years in business, the company has prioritized investments in employee growth and development with management programs, career skills training and mentorship programs.
Just as Kevin and Alex took advantage of the career growth opportunities offered to them throughout their lengthy careers with the firm, they now serve as mentors to junior staff, and will continue to take on employee development roles in addition to their regular responsibilities.